Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 13, 2013 - Issue 3
Submit an article Journal homepage
2,965
Views
24
CrossRef citations to date
0
Altmetric
Theme: Demyelinating Diseases - Special Report

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance

Ellen Lu Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
,
Bing Wei Wang Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
,
Colleen Guimond Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
,
Anne Synnes Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada; Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada
,
A Dessa Sadovnick Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
,
Leanne Dahlgren Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, Canada; Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, Canada
,
Anthony Traboulsee Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
&
Helen Tremlett Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. [email protected]
 show all
Pages 251-261 | Published online: 09 Jan 2014

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jack Burks, Thomas S Marshall & Xiaolan Ye. (2017) Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis. ClinicoEconomics and Outcomes Research 9, pages 251-260.
Read now
Eleonora Cocco & Maria Giovanna Marrosu. (2014) The current role of mitoxantrone in the treatment of multiple sclerosis. Expert Review of Neurotherapeutics 14:6, pages 607-616.
Read now
Thierry Aupérin. (2013) Oral available agents in the treatment of RRMS. Drug, Healthcare and Patient Safety 5, pages 199-201.
Read now

Articles from other publishers (21)

Yinxiang Wang, Jue Wang & Juan Feng. (2023) Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options. Autoimmunity Reviews 22:11, pages 103449.
Crossref
Petra Nytrova & Ondrej Dolezal. (2022) Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis. Frontiers in Immunology 13.
Crossref
Giangaetano D’Aleo, Carmela Rifici, Antonina Donato, Francesco Corallo, Marcella Di Cara, Placido Bramanti & Edoardo Sessa. (2020) Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient. Medicine 99:28, pages e21212.
Crossref
Olga Zapletalová. (2019) Multiple sclerosis - maternity and breastfeeding. Neurologie pro praxi 20:1, pages 33-36.
Crossref
Alexander Winkelmann, Paulus Stefan Rommer, Michael Hecker & Uwe Klaus Zettl. (2018) Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater‐blinded analysis of relapse rates during pregnancy and the postnatal period. CNS Neuroscience & Therapeutics 25:1, pages 78-85.
Crossref
Pamela McCombe. (2018) The Short and Long-Term Effects of Pregnancy on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Journal of Clinical Medicine 7:12, pages 494.
Crossref
Mark S. Freedman, Daniel Selchen, Alexandre Prat & Paul S. Giacomini. (2018) Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:5, pages 489-503.
Crossref
L.P. Kotra & J. Park. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 439 473 .
Ralf Gold, Dusan Stefoski, Krzysztof Selmaj, Eva Havrdova, Christopher Hurst, Joan Holman, Belen Tornesi, Surekha Akella & Peter McCroskery. (2016) Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program. Neurology and Therapy 5:2, pages 169-182.
Crossref
Ingrid E. H. Kremer, Silvia M. A. A. Evers, Peter J. Jongen, Trudy van der Weijden, Ilona van de Kolk & Mickaël Hiligsmann. (2016) Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling. PLOS ONE 11:11, pages e0164862.
Crossref
Ralf Gold, J. Theodore Phillips, Eva Havrdova, Amit Bar-Or, Ludwig Kappos, Norman Kim, Tim Thullen, Patricia Valencia, Lauren Oliva, Mark Novas, Jie Li, Marianne T. Sweetser, Nuwan Kurukulasuriya, Vissia Viglietta & Robert J. Fox. (2015) Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience. Neurology and Therapy 4:2, pages 93-104.
Crossref
C. Pozzilli & M. Pugliatti. (2015) An overview of pregnancy-related issues in patients with multiple sclerosis. European Journal of Neurology 22, pages 34-39.
Crossref
Zahra Tolou-Ghamari. (2015) Preliminary Evidence-Based Pharmacotherapy of Mitoxantrone for Multiple Sclerosis in an Iranian Population. Thrita 4:3.
Crossref
Sylvia Klineova, Nesanet Mitiku & Aaron E Miller. (2015) Disease-modifying therapy for multiple sclerosis. Future Neurology 10:3, pages 253-279.
Crossref
Alberto Gajofatto & Maria Donata Benedetti. (2015) Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?. World Journal of Clinical Cases 3:7, pages 545.
Crossref
Amanda N. Hopkins, Taghreed Alshaeri, Seth A. Akst & Jeffrey S. Berger. (2014) Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist. Seminars in Perinatology 38:6, pages 359-369.
Crossref
J. Fagius & J. Burman. (2014) Normal outcome of pregnancy with ongoing treatment with natalizumab. Acta Neurologica Scandinavica 129:6, pages e27-e29.
Crossref
Patricia K. Coyle. (2014) Multiple Sclerosis in Pregnancy. CONTINUUM: Lifelong Learning in Neurology 20:1, pages 42-59.
Crossref
Ellen Lu, Bing Wei Wang, Sura Alwan, Anne Synnes, Leanne Dahlgren, A. Dessa Sadovnick & Helen Tremlett. (2013) A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis. CNS Drugs 28:2, pages 89-94.
Crossref
Gábor Mezo. 2013. Amino Acids, Peptides and Proteins. Amino Acids, Peptides and Proteins 203 252 .
Paul L. McCormack. (2013) Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis. Drugs 73:13, pages 1463-1481.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.